HDAC4 does not act as a protein deacetylase in the postnatal murine brain in vivo

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Mielcarek, Michal ^a   Seredenina, Tamara ^b   Stokes, Matthew P ^c   Osborne, Georgina F ^a   Landles, Christian ^a   Inuabasi, Linda ^a   Franklin, Sophie A ^a   Silva, Jeffrey C ^c   Luthi Carter, Ruth ^b   Beaumont, Vahri ^d   Bates, Gillian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b EPFL   (Switzerland)

^c CELL SIGNALING TECHNOLOGY   (United States)

^d CHDI MANAGEMENT CHDI FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HDAC5 PROTEIN, MOUSE; HISTONE DEACETYLASE;

ACETYLATION; ANIMAL; BRAIN; CYTOPLASM; DNA MICROARRAY; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; NEWBORN; PROTEIN TRANSPORT; REPRODUCIBILITY; UPREGULATION;

ACETYLATION; ANIMALS; ANIMALS, NEWBORN; BRAIN; CYTOPLASM; DOWN-REGULATION; GENE EXPRESSION PROFILING; HISTONE DEACETYLASES; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN TRANSPORT; REPRODUCIBILITY OF RESULTS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84889000595     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080849     Document Type: Article

References (38)

1. Butler R, Bates GP (2006) Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat Rev Neurosci 7: 784-796. doi:10.1038/nrn1989. PubMed: 16988654. (Pubitemid 44435261)
2. Verdin E, Dequiedt F, Kasler HG (2003) Class II histone deacetylases: versatile regulators. Trends Genet 19: 286-293. doi:10.1016/S0168-9525(03)00073- 8. PubMed: 12711221. (Pubitemid 36507011)
3. Parra M, Verdin E (2010) Regulatory signal transduction pathways for class IIa histone deacetylases. Curr Opin Pharmacol 10: 454-460. doi: 10.1016/j.coph.2010.04.004. PubMed: 20447866.
4. Chawla S, Vanhoutte P, Arnold FJL, Huang CLH, Bading H (2003) Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem 85: 151-159. doi:10.1046/j.1471-4159.2003.01648.x. PubMed: 12641737. (Pubitemid 36389705)
5. McKinsey TA, Zhang CL, Olson EN (2000) Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc Natl Acad Sci U S A 97: 14400-14405. doi:10.1073/pnas.260501497. PubMed: 11114197.
6. Lahm A, Paolini C, Pallaoro M, Nardi MC, Jones P et al. (2007) Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A 104: 17335-17340. doi: 10.1073/pnas.0706487104. PubMed: 17956988. (Pubitemid 350219843)
7. Darcy MJ, Calvin K, Cavnar K, Ouimet CC (2010) Regional and subcellular distribution of HDAC4 in mouse brain. J Comp Neurol 518: 722-740. doi:10.1002/cne.22241. PubMed: 20034059.
8. Sando R 3rd, Gounko N, Pieraut S, Liao L, Yates J 3rd et al. (2012) HDAC4 governs a transcriptional program essential for synaptic plasticity and memory. Cell 151: 821-834. doi:10.1016/j.cell.2012.09.037. PubMed: 23141539.
9. Chen B, Cepko CL (2009) HDAC4 regulates neuronal survival in normal and diseased retinas. Science 323: 256-259. doi:10.1126/science.1166226. PubMed: 19131628.
10. Majdzadeh N, Wang L, Morrison BE, Bassel-Duby R, Olson EN et al. (2008) HDAC4 inhibits cell-cycle progression and protects neurons from cell death. Dev Neurobiol 68: 1076-1092. doi:10.1002/dneu.20637. PubMed: 18498087. (Pubitemid 351904928)
11. Kim MS, Akhtar MW, Adachi M, Mahgoub M, Bassel-Duby R et al. (2012) An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci 32: 10879-10886. doi:10.1523/JNEUROSCI.2089-12.2012. PubMed: 22875922.
12. Price V, Wang L, D'Mello SR (2013) Conditional deletion of histone deacetylase-4 in the central nervous system has no major effect on brain architecture or neuronal viability. J Neurosci Res 91: 407-415. doi:10.1002/jnr.23170. PubMed: 23239283.
13. Sailaja BS, Cohen-Carmon D, Zimmerman G, Soreq H, Meshorer E (2012) Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4. Proc Natl Acad Sci U S A 109: E3687-E3695. doi:10.1073/pnas.1209990110. PubMed: 23236169.
14. Bolger TA, Yao TP (2005) Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J Neurosci 25: 9544-9553. doi:10.1523/ JNEUROSCI.1826-05.2005. PubMed: 16221865. (Pubitemid 41464769)
15. Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS et al. (2012) Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 18: 783-790. doi: 10.1038/nm.2709. PubMed: 22466704.
16. Yang W, Zhang J, Wang H, Shen W, Gao P et al. (2011) Peroxisome proliferator-activated receptor gamma regulates angiotensin II-induced catalase downregulation in adventitial fibroblasts of rats. FEBS Lett 585: 761-766. doi:10.1016/j.febslet.2011.01.040. PubMed: 21295034.
17. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X et al. (2004) Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119: 555-566. doi:10.1016/j.cell.2004.10.024. PubMed: 15537544. (Pubitemid 39482354)
18. Stokes MP, Farnsworth CL, Moritz A, Silva JC, Jia X et al. (2012) PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS. Mol Cell Proteomics 11: 187-201. doi:10.1074/mcp.M111.015883. PubMed: 22322096.
19. Rush J, Moritz A, Lee KA, Guo A, Goss VL et al. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23: 94-101. doi:10.1038/nbt1046. PubMed: 15592455. (Pubitemid 41724631)
20. Schwer B, Eckersdorff M, Li Y, Silva JC, Fermin D et al. (2009) Calorie restriction alters mitochondrial protein acetylation. Aging Cell 8: 604-606. doi:10.1111/j.1474-9726.2009.00503.x. PubMed: 19594485.
21. Jeffers V, Sullivan WJ Jr. (2012) Lysine acetylation is widespread on proteins of diverse function and localization in the protozoan parasite Toxoplasma gondii. Eukaryot Cell 11: 735-742. doi:10.1128/EC.00088-12. PubMed: 22544907.
22. Gnad F, Young A, Zhou W, Lyle K, Ong CC et al. (2013) Systems-wide Analysis of K-Ras, Cdc42, and PAK4 Signaling by Quantitative Phosphoproteomics. Mol Cell Proteomics 12: 2070-2080. doi:10.1074/mcp.M112.027052. PubMed: 23608596.
23. Saha RN, Pahan K (2006) HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 13: 539-550. doi:10.1038/sj.cdd.4401769. PubMed: 16167067.
24. Takizawa T, Meshorer E (2008) Chromatin and nuclear architecture in the nervous system. Trends Neurosci 31: 343-352. doi:10.1016/j.tins.2008.03.005. PubMed: 18538423.
25. Grozinger CM, Schreiber SL (2000) Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci U S A 97: 7835-7840. doi:10.1073/pnas.140199597. PubMed: 10869435. (Pubitemid 30460734)
26. Zhao X, Ito A, Kane CD, Liao TS, Bolger TA et al. (2001) The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking. J Biol Chem 276: 35042-35048. doi: 10.1074/jbc.M105086200. PubMed: 11470791.
27. Grozinger CM, Hassig CA, Schreiber SL (1999) Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A 96: 4868-4873. doi:10.1073/pnas.96.9.4868. PubMed: 10220385. (Pubitemid 29214503)
28. Bottomley MJ, Lo Surdo P, Di Giovine P, Cirillo A, Scarpelli R et al. (2008) Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J Biol Chem 283: 26694-26704. doi:10.1074/jbc.M803514200. PubMed: 18614528.
29. Mihaylova MM, Vasquez DS, Ravnskjaer K, Denechaud PD, Yu RT et al. (2011) Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145: 607-621. doi:10.1016/j.cell.2011.03. 043. PubMed: 21565617.
30. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370: 737-749. doi:10.1042/BJ20021321. PubMed: 12429021.
31. Flavell SW, Kim TK, Gray JM, Harmin DA, Hemberg M et al. (2008) Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 60: 1022-1038. doi:10.1016/j.neuron.2008.11.029. PubMed: 19109909.
32. Mielcarek M, Landles C, Weiss A, Bradaia A, Seredenina T et al. (2013) HDAC4 reduction: a novel therpauetic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLOS Biol (in press).
33. Benn CL, Fox H, Bates GP (2008) Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease. Mol Neurodegener 3: 17. doi:10.1186/1750-1326-3- 17. PubMed: 18954449.
34. Mielcarek M, Benn CL, Franklin SA, Smith DL, Woodman B et al. (2011) SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease. PLOS ONE 6: e27746. doi:10.1371/journal.pone.0027746. PubMed: 22140466.
35. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818. doi:10.1002/sim. PubMed: 2218183.
36. Lundgren DH, Martinez H, Wright ME, Han DK (2009) Protein identification using Sorcerer 2 and SEQUEST. Curr Protoc Bioinformatics Chapter 13: Unit 13 13
37. Davies SW, Sathasivam K, Hobbs C, Doherty P, Mangiarini L et al. (1999) Detection of polyglutamine aggregation in mouse models. Methods Enzymol 309: 687-701. doi:10.1016/S0076-6879(99)09045-X. PubMed: 10507055. (Pubitemid 29446480)
38. Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H et al. (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem 285: 8808-8823. doi:10.1074/jbc.M109.075028. PubMed: 20086007.